_id
6919e8743c536f8df2318255
Ticker
GENI.LSE
Name
Genincode PLC
Exchange
LSE
Address
One St. Peters Square, Manchester, United Kingdom, M2 3DE
Country
UK
Sector
Healthcare
Industry
Diagnostics & Research
Currency
GBX
Website
https://www.genincode.com
Description
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology offers patients and physicians with preventative care and treatment strategies. The company's invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a genetic test to help user to adopt cardiovascular prevention assesment; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia FH; SUDD inCode, genetic diagnostic test for familial heart diseases; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis. In addition, the company offers Thrombo inCode Reproductive Health, is a genetic test that evaluates the impact of hereditary thrombophilia in patients with repeated miscarriages; and ROCA Test, a blood test that determines the risk of a woman having ovarian cancer. Further, it engages in the medical and scientific research activities. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.
Last Close
22000
Volume
1104206
Current Price
2
Change
18.181818181818176
Last Updated
2025-12-30T10:57:53.853Z
Image
https://logo.clearbit.com/www.genincode.com
Ipo Date
-
Market Cap
6483534
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
1602000
Cost Of Revenue
753000
Gross Profit
849000
Operating Expenses
3819000
Operating Income
-2970000
Interest Expense
22000
Pretax Income
-2967000
Net Income
-2963000
Eps
-0.01189854711631904
Dividends Per Share
-
Shares Outstanding
286882042
Income Tax Expense
4000
EBITDA
-2335000
Operating Margin
-185.3932584269663
Total Other Income Expense Net
3000
Cash
2438000
Short Term Investments
65000
Receivables
1229000
Inventories
95000
Total Current Assets
3827000
Property Plant Equipment
286000
Total Assets
4221000
Payables
1360000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1558000
Equity
2663000
Bs_currency_symbol
GBP
Depreciation
162000
Change In Working Capital
-932000
Cash From Operations
-3215000
Capital Expenditures
0
Cash From Investing
25000
Cash From Financing
3678000
Net Change In Cash
1328000
Cf_currency_symbol
-
PE
-
PB
187.0236575291025
ROE
-111.26549004881711
ROA
-70.19663586827765
FCF
-3215000
Fcf Percent
-2.0068664169787764
Piotroski FScore
0
Health Score
22
Deep Value Investing Score
4
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3.5
Growth Investing Score
2.5
Momentum Investing Score
5.5
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1602000
Quarters > 0 > income Statement > cost Of Revenue
753000
Quarters > 0 > income Statement > gross Profit
849000
Quarters > 0 > income Statement > operating Expenses
3819000
Quarters > 0 > income Statement > operating Income
-2970000
Quarters > 0 > income Statement > interest Expense
22000
Quarters > 0 > income Statement > pretax Income
-2967000
Quarters > 0 > income Statement > net Income
-2963000
Quarters > 0 > income Statement > eps
-0.01189854711631904
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
249022000
Quarters > 0 > income Statement > income Tax Expense
4000
Quarters > 0 > income Statement > EBITDA
-2335000
Quarters > 0 > income Statement > operating Margin
-185.3932584269663
Quarters > 0 > income Statement > total Other Income Expense Net
3000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2438000
Quarters > 0 > balance Sheet > short Term Investments
65000
Quarters > 0 > balance Sheet > receivables
1229000
Quarters > 0 > balance Sheet > inventories
95000
Quarters > 0 > balance Sheet > total Current Assets
3827000
Quarters > 0 > balance Sheet > property Plant Equipment
286000
Quarters > 0 > balance Sheet > total Assets
4221000
Quarters > 0 > balance Sheet > payables
1360000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1558000
Quarters > 0 > balance Sheet > equity
2663000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-2963000
Quarters > 0 > cash Flow > depreciation
162000
Quarters > 0 > cash Flow > change In Working Capital
-932000
Quarters > 0 > cash Flow > cash From Operations
-3215000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
25000
Quarters > 0 > cash Flow > cash From Financing
3678000
Quarters > 0 > cash Flow > net Change In Cash
1328000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.01189854711631904
Quarters > 0 > ratios > PB
187.0236575291025
Quarters > 0 > ratios > ROE
-111.26549004881711
Quarters > 0 > ratios > ROA
-70.19663586827765
Quarters > 0 > ratios > FCF
-3215000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-2.0068664169787764
Quarters > 0 > health Score
22
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1312000
Quarters > 1 > income Statement > cost Of Revenue
791000
Quarters > 1 > income Statement > gross Profit
521000
Quarters > 1 > income Statement > operating Expenses
3237000
Quarters > 1 > income Statement > operating Income
-2716000
Quarters > 1 > income Statement > interest Expense
25000
Quarters > 1 > income Statement > pretax Income
-2646000
Quarters > 1 > income Statement > net Income
-2005000
Quarters > 1 > income Statement > eps
-0.0113299607458959
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
176964426
Quarters > 1 > income Statement > income Tax Expense
-641000
Quarters > 1 > income Statement > EBITDA
-2446000
Quarters > 1 > income Statement > operating Margin
-207.01219512195124
Quarters > 1 > income Statement > total Other Income Expense Net
70000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1110000
Quarters > 1 > balance Sheet > short Term Investments
55000
Quarters > 1 > balance Sheet > receivables
610000
Quarters > 1 > balance Sheet > inventories
126000
Quarters > 1 > balance Sheet > total Current Assets
2104000
Quarters > 1 > balance Sheet > property Plant Equipment
441000
Quarters > 1 > balance Sheet > total Assets
2663000
Quarters > 1 > balance Sheet > payables
612000
Quarters > 1 > balance Sheet > short Term Debt
174000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1536000
Quarters > 1 > balance Sheet > equity
1127000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-2005000
Quarters > 1 > cash Flow > depreciation
175000
Quarters > 1 > cash Flow > change In Working Capital
519000
Quarters > 1 > cash Flow > cash From Operations
-1730000
Quarters > 1 > cash Flow > capital Expenditures
48000
Quarters > 1 > cash Flow > cash From Investing
-48000
Quarters > 1 > cash Flow > cash From Financing
-51000
Quarters > 1 > cash Flow > net Change In Cash
-1805000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0113299607458959
Quarters > 1 > ratios > PB
314.0451215616681
Quarters > 1 > ratios > ROE
-177.90594498669032
Quarters > 1 > ratios > ROA
-75.29102515959444
Quarters > 1 > ratios > FCF
-1778000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.3551829268292683
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1389000
Quarters > 2 > income Statement > cost Of Revenue
659000
Quarters > 2 > income Statement > gross Profit
730000
Quarters > 2 > income Statement > operating Expenses
3205000
Quarters > 2 > income Statement > operating Income
-2475000
Quarters > 2 > income Statement > interest Expense
23000
Quarters > 2 > income Statement > pretax Income
-2437000
Quarters > 2 > income Statement > net Income
-2429000
Quarters > 2 > income Statement > eps
-0.0140462270642865
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
172929000
Quarters > 2 > income Statement > income Tax Expense
-8000
Quarters > 2 > income Statement > EBITDA
-2303000
Quarters > 2 > income Statement > operating Margin
-178.18574514038878
Quarters > 2 > income Statement > total Other Income Expense Net
38000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
2915000
Quarters > 2 > balance Sheet > short Term Investments
38000
Quarters > 2 > balance Sheet > receivables
805000
Quarters > 2 > balance Sheet > inventories
79000
Quarters > 2 > balance Sheet > total Current Assets
3837000
Quarters > 2 > balance Sheet > property Plant Equipment
547000
Quarters > 2 > balance Sheet > total Assets
4661000
Quarters > 2 > balance Sheet > payables
1378000
Quarters > 2 > balance Sheet > short Term Debt
162000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1847000
Quarters > 2 > balance Sheet > equity
2814000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-2429000
Quarters > 2 > cash Flow > depreciation
172000
Quarters > 2 > cash Flow > change In Working Capital
-224000
Quarters > 2 > cash Flow > cash From Operations
-3389000
Quarters > 2 > cash Flow > capital Expenditures
1000
Quarters > 2 > cash Flow > cash From Investing
60000
Quarters > 2 > cash Flow > cash From Financing
3696000
Quarters > 2 > cash Flow > net Change In Cash
431000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0140462270642865
Quarters > 2 > ratios > PB
122.90618336886995
Quarters > 2 > ratios > ROE
-86.31840796019901
Quarters > 2 > ratios > ROA
-52.11328041192878
Quarters > 2 > ratios > FCF
-3390000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-2.4406047516198703
Quarters > 2 > health Score
22
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
694500
Quarters > 3 > income Statement > cost Of Revenue
329500
Quarters > 3 > income Statement > gross Profit
365000
Quarters > 3 > income Statement > operating Expenses
1602500
Quarters > 3 > income Statement > operating Income
-1237500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1218500
Quarters > 3 > income Statement > net Income
-1214500
Quarters > 3 > income Statement > eps
-0.00702311353214325
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
172929000
Quarters > 3 > income Statement > income Tax Expense
4000
Quarters > 3 > income Statement > EBITDA
-1151500
Quarters > 3 > income Statement > operating Margin
-178.18574514038878
Quarters > 3 > income Statement > total Other Income Expense Net
19000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2915000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
805000
Quarters > 3 > balance Sheet > inventories
79000
Quarters > 3 > balance Sheet > total Current Assets
3837000
Quarters > 3 > balance Sheet > property Plant Equipment
547000
Quarters > 3 > balance Sheet > total Assets
4661000
Quarters > 3 > balance Sheet > payables
1378000
Quarters > 3 > balance Sheet > short Term Debt
81000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1847000
Quarters > 3 > balance Sheet > equity
2814000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-1214500
Quarters > 3 > cash Flow > depreciation
86000
Quarters > 3 > cash Flow > change In Working Capital
-112000
Quarters > 3 > cash Flow > cash From Operations
-1694500
Quarters > 3 > cash Flow > capital Expenditures
500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1848000
Quarters > 3 > cash Flow > net Change In Cash
215500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.00702311353214325
Quarters > 3 > ratios > PB
122.90618336886995
Quarters > 3 > ratios > ROE
-43.159203980099505
Quarters > 3 > ratios > ROA
-26.05664020596439
Quarters > 3 > ratios > FCF
-1695000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-2.4406047516198703
Quarters > 3 > health Score
22
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2701000
Annuals > 0 > income Statement > cost Of Revenue
1275000
Annuals > 0 > income Statement > gross Profit
1426000
Annuals > 0 > income Statement > operating Expenses
6560000
Annuals > 0 > income Statement > operating Income
-5134000
Annuals > 0 > income Statement > interest Expense
48000
Annuals > 0 > income Statement > pretax Income
-5083000
Annuals > 0 > income Statement > net Income
-4434000
Annuals > 0 > income Statement > eps
-0.02533377621543048
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
175023256
Annuals > 0 > income Statement > income Tax Expense
-649000
Annuals > 0 > income Statement > EBITDA
-4688000
Annuals > 0 > income Statement > operating Margin
-190.07774898185858
Annuals > 0 > income Statement > total Other Income Expense Net
51000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
1110000
Annuals > 0 > balance Sheet > short Term Investments
55000
Annuals > 0 > balance Sheet > receivables
610000
Annuals > 0 > balance Sheet > inventories
126000
Annuals > 0 > balance Sheet > total Current Assets
2104000
Annuals > 0 > balance Sheet > property Plant Equipment
441000
Annuals > 0 > balance Sheet > total Assets
2663000
Annuals > 0 > balance Sheet > payables
612000
Annuals > 0 > balance Sheet > short Term Debt
174000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1536000
Annuals > 0 > balance Sheet > equity
1127000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-5083000
Annuals > 0 > cash Flow > depreciation
347000
Annuals > 0 > cash Flow > change In Working Capital
-1363000
Annuals > 0 > cash Flow > cash From Operations
-5173000
Annuals > 0 > cash Flow > capital Expenditures
49000
Annuals > 0 > cash Flow > cash From Investing
50000
Annuals > 0 > cash Flow > cash From Financing
3645000
Annuals > 0 > cash Flow > net Change In Cash
-1374000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.02533377621543048
Annuals > 0 > ratios > PB
406.88636266193436
Annuals > 0 > ratios > ROE
-393.4338952972493
Annuals > 0 > ratios > ROA
-166.50394292151708
Annuals > 0 > ratios > FCF
-5222000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.9333580155497965
Annuals > 0 > health Score
17
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2160000
Annuals > 1 > income Statement > cost Of Revenue
1138000
Annuals > 1 > income Statement > gross Profit
1022000
Annuals > 1 > income Statement > operating Expenses
8173000
Annuals > 1 > income Statement > operating Income
-7151000
Annuals > 1 > income Statement > interest Expense
48000
Annuals > 1 > income Statement > pretax Income
-7023000
Annuals > 1 > income Statement > net Income
-7016000
Annuals > 1 > income Statement > eps
-0.0732230169164581
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
95816866
Annuals > 1 > income Statement > income Tax Expense
-7000
Annuals > 1 > income Statement > EBITDA
-6648000
Annuals > 1 > income Statement > operating Margin
-331.0648148148148
Annuals > 1 > income Statement > total Other Income Expense Net
128000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
2484000
Annuals > 1 > balance Sheet > short Term Investments
42000
Annuals > 1 > balance Sheet > receivables
509000
Annuals > 1 > balance Sheet > inventories
84000
Annuals > 1 > balance Sheet > total Current Assets
3192000
Annuals > 1 > balance Sheet > property Plant Equipment
707000
Annuals > 1 > balance Sheet > total Assets
4186000
Annuals > 1 > balance Sheet > payables
1194000
Annuals > 1 > balance Sheet > short Term Debt
156000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2897000
Annuals > 1 > balance Sheet > equity
1289000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-7016000
Annuals > 1 > cash Flow > depreciation
351000
Annuals > 1 > cash Flow > change In Working Capital
-753000
Annuals > 1 > cash Flow > cash From Operations
-7506000
Annuals > 1 > cash Flow > capital Expenditures
38000
Annuals > 1 > cash Flow > cash From Investing
136000
Annuals > 1 > cash Flow > cash From Financing
-94000
Annuals > 1 > cash Flow > net Change In Cash
-7248000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.0732230169164581
Annuals > 1 > ratios > PB
194.7557710783553
Annuals > 1 > ratios > ROE
-544.2979053529868
Annuals > 1 > ratios > ROA
-167.60630673674152
Annuals > 1 > ratios > FCF
-7544000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-3.4925925925925925
Annuals > 1 > health Score
13
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1430000
Annuals > 2 > income Statement > cost Of Revenue
798000
Annuals > 2 > income Statement > gross Profit
632000
Annuals > 2 > income Statement > operating Expenses
6531000
Annuals > 2 > income Statement > operating Income
-5899000
Annuals > 2 > income Statement > interest Expense
20000
Annuals > 2 > income Statement > pretax Income
-5746000
Annuals > 2 > income Statement > net Income
-5559000
Annuals > 2 > income Statement > eps
-0.05801692574666343
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
95816866
Annuals > 2 > income Statement > income Tax Expense
-187000
Annuals > 2 > income Statement > EBITDA
-5569000
Annuals > 2 > income Statement > operating Margin
-412.5174825174825
Annuals > 2 > income Statement > total Other Income Expense Net
153000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
9732000
Annuals > 2 > balance Sheet > short Term Investments
16000
Annuals > 2 > balance Sheet > receivables
614000
Annuals > 2 > balance Sheet > inventories
20000
Annuals > 2 > balance Sheet > total Current Assets
10485000
Annuals > 2 > balance Sheet > property Plant Equipment
1002000
Annuals > 2 > balance Sheet > total Assets
11797000
Annuals > 2 > balance Sheet > payables
1416000
Annuals > 2 > balance Sheet > short Term Debt
138000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3897000
Annuals > 2 > balance Sheet > equity
7900000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-5745000
Annuals > 2 > cash Flow > depreciation
163000
Annuals > 2 > cash Flow > change In Working Capital
1897000
Annuals > 2 > cash Flow > cash From Operations
-3762000
Annuals > 2 > cash Flow > capital Expenditures
849000
Annuals > 2 > cash Flow > cash From Investing
-849000
Annuals > 2 > cash Flow > cash From Financing
-47000
Annuals > 2 > cash Flow > net Change In Cash
-4822000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.05801692574666343
Annuals > 2 > ratios > PB
31.77723910379747
Annuals > 2 > ratios > ROE
-70.36708860759494
Annuals > 2 > ratios > ROA
-47.12214969907604
Annuals > 2 > ratios > FCF
-4611000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.2244755244755243
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1154000
Annuals > 3 > income Statement > cost Of Revenue
561000
Annuals > 3 > income Statement > gross Profit
593000
Annuals > 3 > income Statement > operating Expenses
4127000
Annuals > 3 > income Statement > operating Income
-3534000
Annuals > 3 > income Statement > interest Expense
1214000
Annuals > 3 > income Statement > pretax Income
-4136000
Annuals > 3 > income Statement > net Income
-4142000
Annuals > 3 > income Statement > eps
-0.08198375348027664
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
50522205
Annuals > 3 > income Statement > income Tax Expense
6000
Annuals > 3 > income Statement > EBITDA
-4101000
Annuals > 3 > income Statement > operating Margin
-306.2391681109185
Annuals > 3 > income Statement > total Other Income Expense Net
10000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
14554000
Annuals > 3 > balance Sheet > short Term Investments
4000
Annuals > 3 > balance Sheet > receivables
265000
Annuals > 3 > balance Sheet > inventories
14000
Annuals > 3 > balance Sheet > total Current Assets
14971000
Annuals > 3 > balance Sheet > property Plant Equipment
46000
Annuals > 3 > balance Sheet > total Assets
15210000
Annuals > 3 > balance Sheet > payables
345000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1492000
Annuals > 3 > balance Sheet > equity
13718000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-4137000
Annuals > 3 > cash Flow > depreciation
35000
Annuals > 3 > cash Flow > change In Working Capital
774000
Annuals > 3 > cash Flow > cash From Operations
-3024000
Annuals > 3 > cash Flow > capital Expenditures
145000
Annuals > 3 > cash Flow > cash From Investing
-145000
Annuals > 3 > cash Flow > cash From Financing
15856000
Annuals > 3 > cash Flow > net Change In Cash
12551000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.08198375348027664
Annuals > 3 > ratios > PB
9.649232912961073
Annuals > 3 > ratios > ROE
-30.193905817174517
Annuals > 3 > ratios > ROA
-27.23208415516108
Annuals > 3 > ratios > FCF
-3169000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.746100519930676
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.01189854711631904
Valuation > metrics > PB
187.0236575291025
Valuation > final Score
20
Valuation > verdict
6134.1% Overvalued
Profitability > metrics > ROE
-111.26549004881711
Profitability > metrics > ROA
-77.42356937548995
Profitability > metrics > Net Margin
-1.8495630461922596
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5850544498685692
Risk > metrics > Interest Coverage
-135
Risk > final Score
-492
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.813970588235294
Liquidity > metrics > Quick Ratio
2.7441176470588236
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-405
Prev Risks > 1
-382
Prev Risks > 2
-26
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:01:36.649Z
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology offers patients and physicians with preventative care and treatment strategies. The company's invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a genetic test to help user to adopt cardiovascular prevention assesment; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia FH; SUDD inCode, genetic diagnostic test for familial heart diseases; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis. In addition, the company offers Thrombo inCode Reproductive Health, is a genetic test that evaluates the impact of hereditary thrombophilia in patients with repeated miscarriages; and ROCA Test, a blood test that determines the risk of a woman having ovarian cancer. Further, it engages in the medical and scientific research activities. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Genincode PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.